Ginkgo Bioworks Holdings Inc. (NYSE: DNA) reported first quarter 2026 revenue of $19 million, down 49% from $38 million in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE